logo
Sensex and Nifty slide 1 per cent, investors' wealth erodes by Rs 6 lakh crore

Sensex and Nifty slide 1 per cent, investors' wealth erodes by Rs 6 lakh crore

Indian stock market fell sharply on Thursday with the benchmarks -NSE Nifty and BSE Sensex - sliding 1% each. At close, the Sensex stood at the 81,691.98 level, falling 823.16 points, or 1%, while the NIFTY50 index settled at the 24,888.20 level, sliding 253.20 points, or 1.01%.
The sell-off is attributed to rising geopolitical tensions in the Middle East and investors turning cautious ahead of the U.S. inflation data.
'The downturn was attributed to intensified profit-booking and risk-off sentiment, as escalating geopolitical tensions in the Middle East overshadowed positive macro cues such as softening inflation and encouraging trade data. Investor mood remained cautious ahead of further developments on the US-China trade front, adding to market uncertainty,' said Bajaj Broking Research.
The broader markets underperformed, with the Nifty Midcap 100 and Smallcap 100 indices falling 1.6% and 1.78%, respectively, highlighting heightened selling pressure. Sectoral performance was uniformly weak, with all major indices closing in the red. Nifty Realty and Nifty Energy led the decline, shedding 2% and 2.04%, respectively.
Investors lost Rs 6 lakh crore on Thursday as the overall market capitalisation of firms listed on the BSE dropped to nearly Rs 449.6 lakh crore from about Rs 455.6 lakh crore in the previous session.
Vinod Nair, Head of Research, Geojit Investments said that valuation concerns and rising oil prices—driven by Middle East tensions, are fuelling risk aversion among investors. He added that adding to the uncertainty, the U.S. is considering unilateral tariff hikes on several key trading partners, with a decision expected within the next one to two weeks, ahead of an early July deadline.
Pranay Aggarwal, Director and CEO of Stoxkart said that weak global cues, particularly concerns around sticky US inflation data and the possibility of delayed interest rate cuts by the Federal Reserve, weighed heavily on investor sentiment. Domestically, markets saw profit booking across the board following the recent post-election rally. Key sectors such as banking, IT, and FMCG came under significant pressure, dragging the indices lower.
'Looking ahead, market participants are likely to remain cautious in the near term as they await clarity on global monetary policy direction and domestic macroeconomic data,' added Aggarwal.
In the Nifty50 pack, 43 stocks declined while only 7 advanced on Thursday. Tata Motors was the top loser, falling 2.98%, followed by Titan (-2.62%), Trent (-2.62%), Shriram Finance (-2.57%) and Coal India (-2.51%).
Meanwhile, gold is witnessing a fresh leg of safe-haven buying, amid escalating geopolitical and economic risks. Gold prices jumped Rs 850 to Rs 99,340 per 10 grams in the national capital on Thursday, according to the All India Sarafa Association. The yellow metal of 99.5% purity climbed Rs 800 to Rs 98,800 per 10 grams (inclusive of all taxes).

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mont Vert signs $500 mn deal to build medical university in Kazakhstan
Mont Vert signs $500 mn deal to build medical university in Kazakhstan

Business Standard

time26 minutes ago

  • Business Standard

Mont Vert signs $500 mn deal to build medical university in Kazakhstan

Pune-based realty group Mont Vert Group has signed a USD 500 million (around Rs 4,300 crore) contract with Kazakhstan's Big B Corp for developing a medical university and a hospital, according to a statement. Mont Vert Group will be responsible for the construction and development activities related to the project, UK-based SRAM & MRAM Group said in the statement. UK-based SRAM & MRAM Group in partnership with Big B Corporation and KAZIND Medical Group of Kazakhstan is developing a private healthcare facility in Kazakhstan. The agreement was made possible through the efforts of Big B Corporation Director Ajay Bhandari and SRAM & MRAM Group Director Mahendra Joshi, the statement said. The group in October last year announced getting approval from the Kazakh government for 243 hectares of land at Astana and 100 hectares at Almaty for Medical University, a multi-specialty Hospital and a 5-star hotel. The medical college will teach 10,000 students and have a multi-specialty hospital with 1,000 beds. "Mont Vert Group represents the highest standards of Indian real estate leadership," said Sailesh Lachu Hiranandani, Chairman, SRAM & MRAM Group. SRAM & MRAM Group, a global conglomerate with interests across fintech, healthcare, AI, agriculture, biotechnology, and more, recently completed 30 years of operations. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Bain Capital-backed CitiusTech exploring acquisitions, to evaluate IPO
Bain Capital-backed CitiusTech exploring acquisitions, to evaluate IPO

Mint

time28 minutes ago

  • Mint

Bain Capital-backed CitiusTech exploring acquisitions, to evaluate IPO

Bain Capital-backed CitiusTech, a healthcare technology services company, is planning to grow through acquisitions and will evaluate an IPO this year, either in the US or India, chief executive officer (CEO) Rajan Kohli told Mint in an interview. 'It is very much in our growth path," Kohli said, referring to the company's plan to list on the exchanges. 'We will evaluate [it] this year if the markets are good," he said, adding that the company will evaluate listing in either India or the US. The firm's primary market is the US, accounting for 95% of its revenues. Its investors are Bain Capital Private Equity and EQT Private Capital Asia (previously Baring Private Equity Asia). Also read: FPI Tracker: Telecom, services, capital goods corner major chunk of inflows; IT, healthcare face heavy selling in May In 2022, Bloomberg reported, citing people in the know, that CitiusTech had filed confidentially for a US IPO. The health tech firm is planning expansions in Europe and Japan, as demand for healthcare technology services increases among medtech, healthcare, and life sciences companies. Kohli said that the firm's specialised focus on healthcare gives it an edge over large Indian IT service companies that cater to various industries. A few other Indian companies are focused solely on healthcare tech services, like IKS Health, which was listed on the exchanges in December 2024 and posted ₹2,664 crore revenue in FY25. Acquisitions drive growth The firm is looking at acquisitions this year to drive growth. 'We didn't make any acquisitions for the last two years because the valuation was not great in the market," Kohli said, adding that this year the company is targeting two acquisitions, provided it finds targets that meet its requirements. CitiusTech is exploring acquisition options which would strengthen its foray into Europe as well as enhance its abilities in the healthcare provider market. Also read: Jainik Power and Cables IPO allotment to be out soon: Here are steps to check status online and GMP The company had previously stated a target of $1 billion in revenue by FY28, which it is still aiming for, Kohli said. 'On an organic basis, we continue to grow as per plan," he said. The company is expecting mid-teens revenue growth in FY26, after high single-digit revenue growth in FY25, Kohli said. While it hasn't yet posted its FY25 results, it clocked revenue of ₹3,536 crore and a profit of ₹350 crore in FY24. GenAI tailwind Kohli sees GenAI as a significant tailwind driving growth, as companies look for cost optimisation solutions. '...today, 25% of our clients give us the opportunity to use GenAI tools. I think in one or two years, 80-100% of our clients will allow GenAI-produced code into their environment," he said. Also read: Aten Papers & Foam IPO Day 1: Check subscription status, GMP, and other details Being a healthcare-focused service provider gives CitiusTech an edge as well, according to Kohli. 'It is a huge advantage being just focused on healthcare because a lot of our clients buy us because of our specialised capabilities. All our investment, all our R&D, all our training goes into healthcare only," he said.

Ratnaafin's Debut Campaign ‘Ratnaafin Hai Toh Possible Hai' Launched to Empower MSME Entrepreneurs in India
Ratnaafin's Debut Campaign ‘Ratnaafin Hai Toh Possible Hai' Launched to Empower MSME Entrepreneurs in India

Fashion Value Chain

time31 minutes ago

  • Fashion Value Chain

Ratnaafin's Debut Campaign ‘Ratnaafin Hai Toh Possible Hai' Launched to Empower MSME Entrepreneurs in India

Ratnaafin, an NBFC focused on empowering MSMEs and small business owners with customised financial solutions to make their dreams accessible, announces the launch of its new film, celebrating entrepreneurs. Ratnaafin has consistently bridged the credit gap by offering business loans, solar loans, supply chain finance, machinery loans, and more-helping enterprises scale, innovate, and thrive in the Indian business community. From business loans to solar financing, working capital to micro loans against property, Ratnaafin offers tailored products for real business needs and has served over 25,000+ customers across 35 branches in India. Saatchi & Saatchi is the creative partner and ideator behind the campaign's concept and execution, capturing the grit that defines an Indian entrepreneur's journey through this film. Watch the film – The TVC follows the lives of four small business owners across industries-a printing press operator expanding production, a Kirana shopkeeper upgrading his retail operations, a home-based achaar brand reaching wider markets, and a boutique owner growing her brand. As we follow their stories, struggles, and successes, we witness the sheer perseverance that defines the Indian entrepreneur. The campaign gives us a glimpse into the importance of choosing the right financial partner to guarantee the success of an MSME. Whether its upgrading a Kirana store, expanding a home-based achaar business, or elevating a boutique's brand presence, the right partner makes all the difference. Entrepreneurial success in a dynamic and competitive landscape relies as much on funding as it does on human resilience and grit. Malav Desai, Managing Director & CEO, Ratnaafin, said, 'This campaign reflects our core belief – that with the right partner, even the boldest dreams are achievable. 'Ratnaafin Hai Toh Possible Hai' goes beyond transactional finance to celebrate the spirit of India's business owners. At its core, this is about trust, support, and enabling the backbone of our economy – our MSMEs.' Sunay Jain, Head – Marketing and Digital Business at Ratnaafin, proudly added, 'Businesses are more than balance sheets. At Ratnaafin, we look deeper-into the midnight oil burned, the risks taken, and the perseverance that MSME owners show every single day. While others may look at paperwork, we see passion. We believe your work speaks louder than your name. That's the kind of business we back. Because when your kaam is strong, your name builds itself.' Ratnaafin is proud to be recognised as a CRISIL A+ rated, stable, and trusted NBFC with a strong foundation in financial discipline. Entrepreneurial resilience is the centrepiece of this campaign, reinforced by Ratnaafin's unwavering support-not just as a lender, but as a true partner. Running across digital platforms, social media, and regional television channels, the campaign showcases how every step, every challenge, and every decision is taken together-with confidence, courage, and cooperation. This campaign, as Ratnaafin's first foray into nationwide brand-building, marks a crucial milestone, with a poignant storyline that goes beyond numbers and touches hearts. It shows that business is more than balance sheets-it's about showing up every day, being relentless in the face of hardship, and doing whatever it takes to make your dreams possible. That is what Indian entrepreneurs are made of, and that is what Ratnaafin acknowledges. Rohit Malkani, CCO, Saatchi & Saatchi, said, 'Jo pai pai se shuru kiya, wo business badhta jayega' reflects the heart of the film. It's a message from one business owner to another. It's not about struggle or success. It's about belief. Belief that if you keep building and showing up every day, what starts small will grow. That's the feeling we wanted to leave people with.' About Ratnaafin Ratnaafin is an RBI-registered NBFC dedicated to empowering MSMEs, business owners, and entrepreneurs with accessible and customised financial solutions. The company has consistently bridged the credit gap by offering business loans, solar loans, supply chain finance, machinery loans, and more-helping enterprises scale, innovate, and thrive. Its deep understanding of India's evolving business landscape makes Ratnaafin the perfect partner in an entrepreneur's financial journey. A seamless digital interface, speedy approvals, and need-based products tailored to each client are just a few tools in its arsenal. With a strong commitment to fuelling the entrepreneurial fire of India, Ratnaafin uses its expertise and integrity to turn possibility into success. About Saatchi & Saatchi India Saatchi & Saatchi India, part of the Publicis Groupe India, is a full-service communications agency specializing in traditional and digital advertising, branding, design, UI/UX, content and brand consultancy. Saatchi & Saatchi offers its suite of services across clients like Hero MotoCorp, Renault, NIVEA, Standard Chartered Bank, ITC, Dabur, Akasa Air, Jockey, P&G, Zee, Zepto, ITC, Relaxo and many more. Core to the agency's DNA is a culture of ownership and the belief that 'Our Clients Business is Our Business' which keeps clients' business goals at the heart of everything. The agency has over 350 employees across its offices in Mumbai, Delhi, Kolkata, and Bengaluru.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store